Evaluation of immunogenicity and safety of the diphtheria, tetanus, pertussis and inactivated poliovirus (DPT-IPV) vaccine Squarekids co-administered with GSK Biologicals’ human rotavirus (HRV) vaccine Rotarix (GSK444563) in healthy infants

Trial Identifier: 114720
Sponsor: GlaxoSmithKline
NCTID:: NCT02907216
Start Date: September 2016
Primary Completion Date: May 2017

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description

Trial Locations

Country Location
Japan Chiba, Japan, 274-0063
Japan Chiba, Japan, 299-4503
Japan Okayama, Japan, 701-0205
Japan Saitama, Japan, 360-0018
Japan Saitama, Japan, 350-0001
Japan Tokyo, Japan, 206-0011
Japan Tokyo, Japan, 146-0095
Japan Tokyo, Japan, 183-0042
Japan Tokyo, Japan, 157-0066
Japan Tokyo, Japan, 167-0052
Japan Tokyo, Japan, 190-0023